Fierce Pharma

APRIL 1, 2024

While the market for COVID-19 vaccines has been shrinking lately, an investigation into text messages between Pfizer CEO Albert Bourla and the European Commission’s President Ursula von der Leyen r | The European Public Prosecutor’s Office (EPPO) took over the investigation into COVID vaccine negotiations between the European Commission's president and Pfizer's CEO Albert Bourla, Politico reports.

Marketing 309

Marketing 309

MedCity News

APRIL 1, 2024

The Otsuka Pharmaceutical and Click Therapeutics mobile app Rejoyn received FDA clearance for use as an adjunct to medication in the treatment of major depressive disorder. But Otsuka must overcome hurdles facing digital therapeutics products, which have yet to gain traction among payers. The post FDA Clears the First Digital Therapeutic for Depression, But Will Payers Cover It?

FDA 130

FDA Medical Pharmaceutical Biopharma 130

Fierce Pharma

APRIL 1, 2024

Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. | Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. The two most influential proxy advisory firms are rallying investors to vote against the 2024 pay proposal for Soriot at the company’s annual general meeting this month.

294

294

PharmaVoice

APRIL 1, 2024

Eledon Therapeutics is developing a drug that could facilitate organ transplants from animals to humans as the procedure gains steam.

125

125

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 1, 2024

Shortly after Gilead Sciences teamed up with Carlyle’s Abingworth to fuel further research on its antibody-drug conjugate Trodelvy, Teva is following a similar pathway with an asthma resc | Shortly after Gilead Sciences teamed up with Carlyle’s Abingworth to fuel further research on its antibody-drug conjugate Trodelvy, Teva is following a similar pathway for an asthma rescue inhaler.

292

292

MedCity News

APRIL 1, 2024

The FDA approved AstraZeneca drug Voydeya as an add-on to standard therapies for paroxysmal nocturnal hemoglobinuria, a rare blood disorder. Alexion, now AstraZeneca’s rare disease subsidiary, added the small molecule to its pipeline via a 2019 acquisition.

FDA 116

FDA Biopharma Pharma 116

MedCity News

APRIL 1, 2024

Ever since the Covid-19 pandemic pushed telehealth to the forefront of American healthcare modalities, the genie has emerged from the lamp to quite a mixed crowd of cheerleaders and cheaters.

Healthcare 113

Healthcare Healthcare 113

Fierce Pharma

APRIL 1, 2024

With AstraZeneca’s dominance in the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH) threatened by the recent approval of the first pill on the market for the condition, Novartis’ Fabha | With AstraZeneca’s dominance in the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH) threatened by the recent approval of the first pill on the market for the condition, Novartis’ Fabhalta, AstraZeneca has answered in the United States for its add-on oral treatment in the indication.

FDA 238

FDA Marketing 238

Pharmaceutical Commerce

APRIL 1, 2024

Patients should not have to wait to access the medication they need.

Patients 104

Patients Medical 104

Fierce Pharma

APRIL 1, 2024

After years relying on the U.S. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. | After years relying on the U.S. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market.

Distribution 208

Distribution Government Marketing 208

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Commerce

APRIL 1, 2024

The latest news for pharma industry insiders.

Pharma 104

Pharma 104

MedCity News

APRIL 1, 2024

The modern healthcare environment will require ambidextrous experts in healthcare and AI

Healthcare 104

Healthcare Healthcare Training Medical 104

PharmaVoice

APRIL 1, 2024

Gender diversity in leadership “doesn’t just happen,” — it requires institutional change, from investing in women’s startups to providing more generous family leave.

102

102

Pharmaceutical Commerce

APRIL 1, 2024

Cross-sectional study explores the impact of this monumental Supreme Court ruling.

Management 101

Management Medical 101

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

APRIL 1, 2024

FDA has granted fast track designation to LISCure Biosciences’ investigational drug LB-P8, for the treatment of PSC.

FDA 98

FDA 98

European Pharmaceutical Review

APRIL 1, 2024

New clinical data has demonstrated the potential of a one-time gene therapy for vision loss. REGENXBIO’s Phase I/IIa trial investigated the safety and tolerability of a single dose of subretinal ABBV-RGX-314 for wet age-related macular degeneration (wet AMD). The two-year data showed that ABBV-RGX-314 provided stable or improved visual acuity and retinal thickness in patients.

Consulting 98

Consulting Safety Patients Management 98

Pharmaceutical Technology

APRIL 1, 2024

Discover the groundbreaking patent by Merck & Co Inc for Tricyclic Heterocycle Compounds to combat HIV infection. Learn about the innovative formula and treatment methods for a potent solution in antiretroviral therapy.

98

98

MedCity News

APRIL 1, 2024

Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases.

Biopharma 98

Biopharma 98

Advertisement

pharmaphorum

APRIL 1, 2024

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder

FDA 93

FDA Prescription 93

MedCity News

APRIL 1, 2024

When developing or deploying new algorithms, hospitals and healthcare AI developers must pay close attention to the quality of training datasets, as well as take active steps to mitigate biases, said Divya Pathak, chief data officer at NYC Health + Hospitals, during a recent panel.

Training 87

Training Healthcare Healthcare 87

pharmaphorum

APRIL 1, 2024

Eisai has filed to extend the label for its Alzheimer’s drug Leqembi to include a once-monthly maintenance regimen

92

92

MedCity News

APRIL 1, 2024

When developing or deploying new algorithms, hospitals and healthcare AI developers must pay close attention to the quality of training datasets, as well as take active steps to mitigate biases, said Divya Pathak, chief data officer at NYC Health + Hospitals, during a recent panel discussion. The post ‘Garbage In Is Garbage Out’: Why Healthcare AI Models Can Only Be As Good As The Data They’re Trained On appeared first on MedCity News.

Training 79

Training Healthcare Healthcare 79

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

pharmaphorum

APRIL 1, 2024

AstraZeneca’s Voydeya has been approved by the FDA as an add-on to treatment with Soliris or Ultomiris for rare disease PNH

FDA 81

FDA 81

MedCity News

APRIL 1, 2024

The Otsuka Pharmaceutical and Click Therapeutics mobile app Rejoyn received FDA clearance for use as an adjunct to medication in the treatment of major depressive disorder. But Otsuka must overcome hurdles facing digital therapeutics products, which have yet to gain traction among payers.

FDA 75

FDA Medical Pharmaceutical Biopharma 75

Pharmacy Times

APRIL 1, 2024

Stephanie Ashraf, MD, offered clinical experience in managing insomnia at the American Medical Women’s Association (AMWA) 2024 Annual Meeting.

Management 59

Management Medical 59

Spotio

APRIL 1, 2024

What comes to mind when you think about field sales training? Maybe you imagine stuffy conference rooms or outdated video lessons. Good news: it doesn’t have to be that way! You can design awesome training programs for your sales team. Doing so will improve the performance of your individual reps by an average of 20% ! (This is especially true when it comes to sales training for field techs, who need a solid understanding of the basics.

Training 52

Training Sales Management Prospecting 52

Advertisement

Distribution

Pharmacy Times

APRIL 1, 2024

Tirzepatide is currently approved for management of type 2 diabetes, improving glucose control, facilitating weight loss, and improving cardiovascular disease outcomes.

Management 55

Management 55

PharmaTech

APRIL 1, 2024

Pharmaceutical Technology gives a brief overview of some of developments in manufacturing facilities, including news from W.R. Grace & Co, ITT Inc, and SMC.

Manufacturing 52

Manufacturing Pharmaceutical 52

Pharmacy Times

APRIL 1, 2024

Investigators aimed to determine the impact of psychotherapy or psychopharmacologic treatments on adverse outcomes in individuals with coronary artery disease or heart failure.

52

52

PharmExec

APRIL 1, 2024

Treatment approved in combination with ravulizumab or eculizumab, representing minority demographic still suffering after receiving C5 inhibitor therapy for extravascular haemolysis.

FDA 52

FDA 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales